Table 2

Clinical characteristics of the 14/118 patients who failed primary therapy of suspected microbial keratitis

IDAgeSexDiagnosesDropsSizeTherapyCulture and sensitivity to antibioticsDays treatedSize at changeComplicationOutcome
1/1073FHSVSteroid6.5×7.5Oflox Moraxella sp n/a16.5×7.5perforation, slow healingself sealed, tarsorrhaphy
1/8381FOCPHypromellose3.0×2.0Oflox S aureus yes45.0×2.0perforationPK (@ 12/7)
2/2279MRosacea3.5×3.0Oflox Pneumococcus yes34.0×4.6nilhealed
2/567MV and VII nerve palsy exposure4.5×2.5Oflox Pneumococcus yes34.0×2.0nilpermanent tarsorrhaphy
1/1874MAKC1.0×0.5OfloxCandidano23.0×2.0indolenthealed
2/1370FPK 3/52 for perforated bacterial ulcerSteroid
Antibiotic
4.5×3.0Oflox Pneumococcus yes38.0×8.0graft failedPK (@ 12/7)
2/2770FHSVSteroid
Antibiotic
5.0×4.5Oflox Bacillus sp yes25.0×4.5perforationPK (@ 2/7)
2/2967M1.0×3.0Cef and gentCoagulase negativeStaphylococcus yes163.5×2.0perforationself sealed, but PK (@ 1/12)
2/2441Fblocked lacrimal duct3.5×3.0Oflox Diphtheroids sp yes40.5×0.5new infiltrateshealed
2/888FPK (BK)Steroid
Antibiotic
7.0×3.0Cef and gent Capnocytophage ochracea yes38.5×3.0graft failedPK (@ 6/52)
2/982MPK (BK)Steroid4.0×3.0Cef and gentCoag neg staph and X maltophillia yes no35.0×4.0graft failedPK (@ 4/7)
2/2679M1.0×5.0Cef and gentCoag neg staphno54.0×1.0extended centrallyhealed
1/2470MPK (HSV)Steroid2.5×3.0Cef and gent Ps aeruginosa no22.5×3.0slow healingconj flap
1/4078FBK (rubeosis)Antibiotic6.0×8.0Oflox Ps aeruginosa yes66.0×8.0deterioratedeviscerated